日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology

DNA和RNA谱分析的一致性分析:MD安德森癌症中心IMPACT2精准肿瘤学研究

Schmidt, Stephanie T; Baysal, Mehmet A; Fu, Siqing; Hong, David S; Piha-Paul, Sarina A; Naing, Aung; Rodon Ahnert, Jordi; Yap, Timothy A; Dumbrava, Ecaterina Elena; Beck, Jennifer; Meric-Bernstam, Funda; Tsimberidou, Apostolia Maria

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD安德森癌症中心早期临床试验中入组的晚期非小细胞肺癌患者的治疗反应

Lim, Jeong Uk; Lin, Heather Y; Kang, Lei; Le, Hung; Tang, Tin-Yun; Champiat, Stephane; Dumbrava, Ecaterina Elena; Le, Xiuning; Naing, Aung; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Tsimberidou, Apostolia Maria; Yap, Timothy A; Fu, Siqing; Meric-Bernstam, Funda; Hong, David S

Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion

贝伐珠单抗联合替西罗莫司治疗晚期恶性肿瘤的I期研究:安全性、疗效及卵巢癌扩展研究

Piha-Paul, Sarina A; Tseng, Chieh; Thompson, Emily; Stafford, R Jason; Le, Hung; Kang, Lei; Fu, Siqing; Tsimberidou, Apostolia; Blumenschein, George; Ahnert, Jordi Rodon; Slopis, John M; Hong, David; Naing, Aung; Meric-Bernstam, Funda; Ng, Chaan S; Westin, Shannon; Sood, Anil K

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity

远程医疗作为早期肿瘤临床试验的途径:来自14000名患者的经验教训以及全球可及性和公平性的未来方向

Torrado, Carlos; Andersen, Clark R; Kang, Lei; Brink, Amanda L; Adesoye, Taiwo; Le, Hung; Patterson, Clover J; Poullard, Anna; Osburn, Jessica A; Tan, Harold N; Gouda, Mohamed A; Charles, Sheena; Urschel, Gabriele E; Tang, Tin-Yun; Hong, David S; Champiat, Stephane; Naing, Aung; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E; Piha-Paul, Sarina A; Rodon, Jordi; Yap, Timothy A; Pohlmann, Paula R; Meric-Bernstam, Funda; Fu, Siqing

A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.

针对晚期实体瘤的 B7H3 靶向抗体药物偶联物:一项 1/1b 期试验

Ma Yuxiang, Yang Yunpeng, Huang Yan, Fang Wenfeng, Xue Jinhui, Meng Xiangjiao, Fan Yun, Fu Siqing, Wu Lin, Zheng Yulong, Liu Jian, Liu Zhihua, Zhuang Wu, Rosen Seth, Qu Song, Li Bihui, Li Mingjun, Zhao Yanqiu, Yang Shujun, Ji Yinghua, Sommerhalder David, Luo Suxia, Yang Kunyu, Li Jingao, Lv Dongqing, Zhang Peng, Zhao Yuanyuan, Hong Shaodong, Zhang Yang, Zhao Shen, Chin Steve, Zhang Xian, Lian Wei, Cai Jiaqiang, Xue Tongtong, Zhang Li, Zhao Hongyun

Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer

用于治疗铂耐药性卵巢癌的髓系靶向抗体 PY159 和 PY314

Yeku, Oladapo O; Barve, Minal; Tan, Winston W; Wang, Judy; Patnaik, Amita; LoRusso, Patricia; Richardson, Debra L; Naqash, Abdul Rafeh; Lynam, Sarah K; Fu, Siqing; Gordon, Michael; Hubbard, Joleen; Kummar, Shivaani; Kyriakopoulos, Christos; Dowlati, Afshin; Chamberlain, Marc; Winer, Ira

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

帕博利珠单抗联合瘤内注射诺维梭菌-NT治疗晚期实体瘤患者的Ib期研究。

Nelson Blessie Elizabeth, Janku Filip, Fu Siqing, Dumbrava Ecaterina E, Hong David S, Karp Daniel D, Naing Aung, Rodon Jordi, Tsimberidou Apostolia M, Murthy Ravi, Sheth Rahul A, Amaria Rodabe N, Conley Anthony P, Damodaran Senthil, Raghav Kanwal P S, Carapanceanu Nicoleta, Singh Mahendra Pal, Carapanceanu Valentin, Pezeshki Abdulmohammad, Leontovich Alexey A, Kreider Brent L, Tung David, Varterasian Mary, Khazaie Khashayarsha, Piha-Paul Sarina A

Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit

在免疫疗法试验中调节实体瘤患者的治疗结果:来自 I 期临床试验单元的药物相互作用分析

Braganca Xavier, Camila; Andersen, Clark R; Lim, JoAnn; Slade, Julian H; Bean, Stacie A; Kang, Lei; Le, Hung; Tsimberidou, Apostolia M; Naing, Aung; Hong, David S; Dumbrava, Ecaterina E; Rodon Ahnert, Jordi; Pohlmann, Paula R; Piha-Paul, Sarina A; Champiat, Stephane; Yap, Timothy A; Tang, Tin-Yun; Meric-Bernstam, Funda; Fu, Siqing

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial

来非托利莫德联合伊匹木单抗治疗晚期实体瘤患者:一项 I 期试验

Nardo, Mirella; Gouda, Mohamed A; Reilley, Matthew J; Biter, Amadeo B; Lim, Joann; Bean, Stacie A; Nguyen, Ly M; Bhosale, Priya R; Ager, Casey R; Couillault, Coline A; Piha-Paul, Sarina A; Fu, Siqing; Tsimberidou, Apostolia M; Yap, Timothy A; Naing, Aung; Rodon, Jordi; Subbiah, Vivek; Karp, Daniel D; Curran, Michael A; Hong, David S

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma

塞利尼索联合免疫检查点阻断疗法治疗晚期肾细胞癌患者的 IB 期试验

Alhalabi, Omar; Gouda, Mohamed A; Milton, Denái R; Momin, Hassan Ahmed; Yilmaz, Bulent; Stephen, Bettzy; Ejezie, Chinenye Lynette; Moyers, Justin Tyler; Gurses, Serdar A; How, Jeffrey; Fu, Siqing; Rodon, Jordi; Hong, David S; Piha-Paul, Sarina A; Subbiah, Vivek; Elena Dumbrava, Ecaterina; Karp, Daniel D; Janku, Filip; Meric-Bernstam, Funda; Tannir, Nizar M; Naing, Aung